http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2008107634-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_669c01133740c5233f2c8738904ea3af
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G02F1-141
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G02F1-1337
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G02F1-1368
filingDate 2006-10-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cdf7edabe42a12441c5063c3a3ed7bd5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_470221332e9ab19a2ac7aeac4dedd260
publicationDate 2008-05-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-2008107634-A
titleOfInvention Liquid crystal display element
abstract A main object of the present invention is to provide a liquid crystal display element using a ferroelectric liquid crystal exhibiting monostability and capable of controlling the direction of spontaneous polarization of the ferroelectric liquid crystal. And The present invention is a first alignment treatment substrate having a first alignment film, which is a photo-alignment film containing a photoisomerizable material, and a photo-alignment film or a rubbing film containing a photo-dimerization-type material. A liquid crystal display element comprising: a second alignment treatment substrate having a second alignment film; and a liquid crystal layer formed between the first alignment treatment substrate and the second alignment treatment substrate and containing a ferroelectric liquid crystal. When a voltage is applied so that the dielectric liquid crystal exhibits monostability and the second electrode layer of the second alignment film-treated substrate is a negative electrode, the molecular direction is parallel to the substrate surface and the tilt angle The above object is achieved by providing a liquid crystal display element characterized in that the liquid crystal display element changes about twice as much as. [Selection] Figure 3
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2011215210-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011062225-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2013156449-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9024053-B2
priorityDate 2006-10-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H03243915-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2005234550-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID314553
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426126171
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426228520
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID444539
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16723172
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394802
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID408299504
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID408299503
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394328
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394277
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID85450
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8452
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457814460
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458399660
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6993312
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID314553
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7189
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2272
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419546720
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414844687
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419526415
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419537837

Total number of triples: 41.